These data indicate that it promotes tumor aggressiveness by activating key signaling pathways and inducing EMT, making targeting GOLPH3 and its related pathways an appealing therapeutic approach for treating gastric cancer [40]. This evidence concerns the gene GOLPH3 and gastric cancer.